Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. announced a non‑brokered private placement of at least 4,285,715 units at $0.70 per unit, targeting gross proceeds of a minimum of approximately $3 million.
  • Each unit consists of one common share and one warrant to purchase an additional common share at $0.85 exercisable for 12 months after closing; the company may also issue up‑to‑8% finder’s fees and non‑transferable warrants on the proceeds.
  • Net proceeds are earmarked for digital marketing, customer acquisition, operating & administrative expenses (including salaries), research & development, and general working capital.

Key Details

  • Units Offered: Minimum 4,285,715 units
  • Price per Unit: $0.70
  • Minimum Gross Proceeds: ≈ $3,000,000
  • Unit Composition:
  • 1 common share
  • 1 warrant to purchase 1 additional common share at an exercise price of $0.85 (exercisable for 12 months post‑closing)
  • Financing Exemption: Listed issuer financing exemption under NI 45‑106 Part 5A (LIFE Exemption), available to Canadian investors outside Quebec; no hold period required.
  • Potential Finder’s Fee: Up to 8% of aggregate gross proceeds, payable upon closing.
  • Additional Warrants: Non‑transferable warrants equal to up to 8% of units issued, exercisable at $0.85 within 12 months from the Closing Date.
  • Use of Proceeds:
  • Digital marketing & customer acquisition
  • Operating and administrative expenses (including salaries)
  • Research & development
  • General working capital
  • Closing Timeline: Expected on or about January 19, 2026, subject to receipt of minimum subscriptions and required approvals (e.g., CSE approval).
  • Offering Documentation: Available at www.sedarplus.ca and the company website (www.rocketdoctor.ai).

Notable Quotes

  • “We are pleased to announce this financing, which will enable us to accelerate our growth initiatives, expand our AI‑driven healthcare platform, and better serve underserved communities,” – Dr. Essam Hamza, CEO.
Read the original news release →

More from Rocket Doctor AI Inc.